company background image
506820 logo

AstraZeneca Pharma India BSE:506820 Stock Report

Last Price

₹7.55k

Market Cap

₹188.8b

7D

5.8%

1Y

61.9%

Updated

01 Nov, 2024

Data

Company Financials

AstraZeneca Pharma India Limited

BSE:506820 Stock Report

Market Cap: ₹188.8b

506820 Stock Overview

A biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally.

506820 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health5/6
Dividends2/6

AstraZeneca Pharma India Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AstraZeneca Pharma India
Historical stock prices
Current Share Price₹7,550.30
52 Week High₹8,139.85
52 Week Low₹4,050.15
Beta0.30
11 Month Change-2.42%
3 Month Change7.25%
1 Year Change61.88%
33 Year Change147.94%
5 Year Change203.18%
Change since IPO12,917.76%

Recent News & Updates

Recent updates

Shareholder Returns

506820IN PharmaceuticalsIN Market
7D5.8%2.6%2.3%
1Y61.9%59.1%37.9%

Return vs Industry: 506820 exceeded the Indian Pharmaceuticals industry which returned 58.7% over the past year.

Return vs Market: 506820 exceeded the Indian Market which returned 37.7% over the past year.

Price Volatility

Is 506820's price volatile compared to industry and market?
506820 volatility
506820 Average Weekly Movement7.3%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 506820 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 506820's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1979940Sanjeev Panchalwww.astrazeneca.in

AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease, renal, and metabolism medicines under the CRESTOR, Forxiga, BRILINTA, Xigduo, and Seloken XL brand names; oncology medicines under the TAGRISSO, CALQUENCE, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes and immunology diseases.

AstraZeneca Pharma India Limited Fundamentals Summary

How do AstraZeneca Pharma India's earnings and revenue compare to its market cap?
506820 fundamental statistics
Market cap₹188.76b
Earnings (TTM)₹958.60m
Revenue (TTM)₹13.88b

196.9x

P/E Ratio

13.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
506820 income statement (TTM)
Revenue₹13.88b
Cost of Revenue₹7.21b
Gross Profit₹6.67b
Other Expenses₹5.71b
Earnings₹958.60m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 13, 2024

Earnings per share (EPS)38.34
Gross Margin48.07%
Net Profit Margin6.91%
Debt/Equity Ratio0.6%

How did 506820 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

37%

Payout Ratio